<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S2825 IS: Ensuring Safe Access to Prescription Medication Act of 2014</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2014-09-16</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress><session>2d Session</session>
		<legis-num>S. 2825</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20140916">September 16, 2014</action-date>
			<action-desc><sponsor name-id="S307">Mr. Brown</sponsor> (for himself and <cosponsor name-id="S287">Mr. Cornyn</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSJU00">Committee on the Judiciary</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Controlled Substances Act to treat as dispensing the delivery of a controlled
			 substance by a pharmacy to a practitioner, pursuant to a patient-specific
			 prescription of the practitioner, under certain circumstances.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <quote><short-title>Ensuring Safe Access to Prescription Medication Act of 2014</short-title></quote>.</text>
		</section><section id="idD0D95B8C57004503BB9DC124F1138FF7"><enum>2.</enum><header>Delivery of controlled substances by a pharmacy to a practitioner pursuant to a patient-specific
			 prescription</header><text display-inline="no-display-inline">Section 102(10) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802(10)</external-xref>) is amended—</text><paragraph id="id9C2D5E9DF4134C69B4BB24D12169D7B1"><enum>(1)</enum><text>by striking <quote>(10) The term <term>dispense</term> means to deliver</quote> and inserting the following:</text><quoted-block display-inline="no-display-inline" id="id9177E67D25D549B6AAA47FF1789BCDF2" style="OLC"><paragraph id="id359A09EFEFB543BE8479EFCE54825902" indent="up1"><enum>(10)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id5FDB35F954A2437D8E1576802A790DE9"><enum>(A)</enum><text>The term <term>dispense</term> means—</text><clause id="id442B7C5DA9664CFB939CA58B39B7F88D" indent="up1"><enum>(i)</enum><text>to deliver</text></clause></subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block></paragraph><paragraph id="idF54581AFE4CA446FA751C3C99D331082"><enum>(2)</enum><text>by striking <quote>The term <term>dispenser</term> means a practitioner</quote> and inserting the following:</text><quoted-block display-inline="no-display-inline" id="id049FFB5D60F047CA9E4DBA59A284FE8B" style="OLC"><subparagraph id="id67735FC9D9554FB6878DA65BC18B6BAB" indent="up2"><enum>(B)</enum><text>The term <term>dispenser</term> means a practitioner</text></subparagraph><after-quoted-block>;</after-quoted-block></quoted-block></paragraph><paragraph id="id018E248C83EF489999B71AA9EC20C6F9"><enum>(3)</enum><text>in subparagraph (A), as so designated—</text><subparagraph id="id32220B680E2C4C1181ED3433CE75197B"><enum>(A)</enum><text>by striking the period at the end and inserting <quote>; or</quote>; and</text></subparagraph><subparagraph id="id778FA8A8FDAE40A59D0BA1E8FBB38AA7"><enum>(B)</enum><text>by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="id79D22D1790A546198E89EFD8B3C0F74D" style="OLC"><clause id="idB2ECB21DE8B54174B799E8FB3AC18C8C" indent="up2"><enum>(ii)</enum><text>to deliver a controlled substance by a pharmacy to a practitioner, including the packaging,
			 labeling, or compounding necessary to prepare the substance for such
			 delivery, if—</text><subclause id="id994A404D723441A3A349DF13ADB0AB07"><enum>(I)</enum><text>such delivery is pursuant to a patient-specific prescription of the practitioner; and</text></subclause><subclause id="id40EC0B7202AD4429B8DAD305D830ED49"><enum>(II)</enum><text>the practitioner has deemed that it is medically necessary, acting in the usual course of
			 professional practice, for the controlled substance to be administered by
			 the practitioner to the patient.</text></subclause></clause><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="id398B72B6263F4AD68F1691A052DCD37A"><enum>(4)</enum><text>in subparagraph (B), as so designated, by striking <quote>to an ultimate user or research subject</quote>.</text>
			</paragraph></section></legis-body>
</bill>


